Acadia Pharmaceuticals | Créances Commerciales



Trade Debtors Changement Date
Acadia Pharmaceuticals USD 119.69M 5.97M 2025-06
ALKERMES USD 356.33M 34.58M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Corcept Therapeutics USD 64.57M 2.75M 2025-06
Cytokinetics USD 8.41M 6.4M 2025-06
Eisai JPY 219.98B 42M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Incyte USD 842.89M 19.76M 2025-06
J&J USD 16.02B 1.18B 2025-03
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Prothena USD 0 0 2024-12
PTC Therapeutics USD 196.13M 14.36M 2025-06
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Acadia Pharmaceuticals Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.